Solventum (SOLV) financials

Health Care Technology · NYSE · Health Care

$81.33 -2.67% Close Oct 30, 2026 Live

Solventum revenue and earnings by year

Solventum's revenue was $8.32 billion in the fiscal year to December 31, 2025, up 0.9% from the year before. Net income was $1.56 billion, 18.7% of revenue. Since the fiscal year to December 31, 2021, revenue has grown 0.5% a year on average.

RevenueNet income
$2.50B$5.00B$7.50B
20212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 5 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue8.338.258.208.138.17
Revenue growth0.9%0.7%0.8%-0.5%—
Gross profit4.454.594.694.704.92
Gross margin53.5%55.6%57.3%57.7%60.2%
Operating income0.631.041.641.691.88
Operating margin7.6%12.6%20.0%20.8%23.0%
Net income1.560.481.351.341.46
Net margin18.7%5.8%16.4%16.5%17.9%
Diluted EPS$8.88$2.76$7.79——
Free cash flow-0.010.811.631.431.93

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SOLV in Markets.

How Solventum makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Product$1.70B76.9%
Cost Of Software & Rentals$511M23.1%

See also: SOLV valuation and P/E history · SOLV returns

No forecast, no recommendation. This page describes Solventum from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.